skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Hi Peter and Team,

What do you think of Cynapsus Therapeutics whose research on a new drug delivery system for Parkinson desease is partially funded by the Michael J. Fox Foundation.

Many thanks!

Michel
Read Answer Asked by Michel L on November 24, 2014
Q: Hi Peter and Team,
I am currently holding GILD Gilead Sciences, CXR Concordia Healthcare and CCT Catamaran.

I am thinking to add one small cap of this sector into my p/f and am looking at GUD Knight Therapeutic and PLI ProMetic Life Science. Which one would you recommend. If you do not these two, pls suggest another one.

Thank you for you healp.
Read Answer Asked by Pui on November 24, 2014
Q: Just read an article about Dollarama. I would appreciate your comments re investment over 3 to 5 years, Thank you for your great independent advice. Much appreciated. Keith
Read Answer Asked by keith on November 24, 2014
Q: I bought this stock a month ago and have a small position and it was my intention to purchase more shares later by dollar cost averaging. I wasn't planning on doing this so quickly but with the recent down grade by Credit Suisse on this company and the price drop in the past few days, would you consider this to be a good time to increase my position. As they are reporting earnings on the 25th could the recent downgrade be attributed to speculation to a possible poorer result and if that is the case would I be better to wait until after the earnings report.

Thank you,

B
Read Answer Asked by Robert on November 21, 2014
Q: Could you give me an outlook for Hammond here.
How is the balance sheet look?
Is this a buy at these levels and is the dividend safe?
Read Answer Asked by Josh on November 21, 2014
Q: Would you comment on Hammond Power please. I'm in no hurry, but I would have thought that the lower C$ would have kicked in by now. Thank you.
Read Answer Asked by james on November 21, 2014
Q: In spite of the much improved 2015 Q1 operating results over 2014 Q1, LMP's stock price had dropped from its highs in August/September by some 40% by early November (although it has a major rally over the last week or so but still down significantly from its highs). Your comments on this company going forward would be much appreciated.

H.S.
Read Answer Asked by Harry on November 20, 2014
Q: I just heard on BNN that someone (didn't catch which brokerage) had just downgraded atd.b which I hold and have done well with, to a SELL. Kind of shocked at that. What do you make of it. Real Bad News to come??? or what
Thank you Peter and Staff for all you do.
I have learned a lot from your site.
Read Answer Asked by Phyllis on November 20, 2014
Q: knight sold their FDA voucher to Gilead for 125 mil US. This just reinforces my view that you want to stay with this mgt. team for the long haul. your comments please.
Read Answer Asked by robert on November 19, 2014
Q: Is there news on PLI? It's hit a new year high.
Read Answer Asked by Brenda on November 18, 2014
Q: I've held this stock for the past couple of years and am pleased it's performed so well. With it having hit annual/lifetime highs is it too late to purchase more? What do you see as it's future prospects and do you plan on writing a report on it anytime?
Thanks!
Read Answer Asked by Brenda on November 18, 2014
Q: I'm looking at investing in a high potential growth stock in pharmaceuticals with a 5 year time horizon. I have narrowed it to three, GUD, Merus (MLS) or Cipher (DND). How would you rank these three as choices one to three. Any others to consider?
Thanks
Jim
Read Answer Asked by Jim on November 16, 2014
Q: Hi, I wonder if you could explain the outperformance of adw.b vs adw.a. I have owned the a shares for a couple of years and while not disappointed I am wondering what it would take to get this somewhat "constipated" stock moving. Thank you very much.
Read Answer Asked by Adam on November 16, 2014
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!